Abstract | BACKGROUND: This analysis explored the relationship between ratings on HAM-D-17 or YMRS and those on the depressive or manic subscale of CGI-S for schizoaffective disorder (CGI-S-SCA). METHODS: This post hoc analysis used the database (N=614) from two 6-week, randomized, placebo-controlled studies of paliperidone ER versus placebo in symptomatic subjects with schizoaffective disorder assessed using HAM-D-17, YMRS, and CGI-S-SCA scales. Parametric and nonparametric regression models explored the relationships between ratings on YMRS and HAM-D-17 and on depressive and manic domains of the CGI-S-SCA from baseline to the 6-week end point. A clinically meaningful improvement was defined as a change of 1 point in the CGI-S-SCA score. No adjustment was made for multiplicity. RESULTS: Multiple linear regression models suggested that a 1-point change in the depressive domain of CGI-S-SCA corresponded to an average 3.6-point (SE=0.2) change in HAM-D-17 score. Similarly, a 1-point change in the manic domain of CGI-S-SCA corresponded to an average 5.8-point (SE=0.2) change in YMRS score. Results were confirmed using local and cumulative logistic regression models in addition to equipercentile linking. LIMITATIONS: Lack of subjects scoring over the complete range of possible scores may limit broad application of the analyses. CONCLUSION: Clinically meaningful score changes in depressive and manic domains of CGI-S-SCA corresponded to approximately 4- and 6-point score changes on HAM-D-17 and YMRS, respectively, in symptomatic subjects with schizoaffective disorder.
|
Authors | Ibrahim Turkoz, Dong-Jing Fu, Cynthia A Bossie, John J Sheehan, Larry Alphs |
Journal | Journal of affective disorders
(J Affect Disord)
Vol. 150
Issue 1
Pg. 17-22
(Aug 15 2013)
ISSN: 1573-2517 [Electronic] Netherlands |
PMID | 23517884
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Review)
|
Copyright | Copyright © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Antipsychotic Agents
- Isoxazoles
- Pyrimidines
- Paliperidone Palmitate
|
Topics |
- Adult
- Antipsychotic Agents
(therapeutic use)
- Bipolar Disorder
(diagnosis)
- Depression
(diagnosis)
- Female
- Humans
- Isoxazoles
(therapeutic use)
- Male
- Paliperidone Palmitate
- Psychiatric Status Rating Scales
- Psychotic Disorders
(diagnosis, drug therapy)
- Pyrimidines
(therapeutic use)
- Severity of Illness Index
|